Skip to content
2000
image of The Role of Immune Markers in Predicting Infectious Complications in Children with Congenital Heart Defects
file format pdf download PDF

Abstract

The literature review presents data from a limited number of available studies conducted over the last two decades on immunological deficiency in congenital heart defects (CHDs), which is the cause of frequent infectious complications before and after cardiac surgery. Several studies based on screenings at various levels indicate the presence of primary and secondary immunodeficiency in CHDs, in particular about 13 genetic syndromes in which CHD is combined with immunodeficiency. The available data suggests a greater severity of immunological disorders in patients with critical CHDs, cyanotic CHDs, and conotruncal defects with T-cell dysfunction and deficiency of immunoglobulins (especially the IgG class, mainly IgG4) than in patients with shunts and obstructive defects. To identify defects in the T- and B-cell components of the immune system, quantification of the DNA of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs)-by-products of the maturation of T- and B-cell receptors-has proven helpful in the world practice of neonatal screening. It allows the evaluation of a number of functionally mature T- and B-cells. In Russia, however, its widespread use started only in 2023. Data on the use of this assay in infants with CHDs are represented by isolated case reports. In Russia, a combination of CHD and primary immunodeficiency was found in 37% of cases in the Sverdlovsk Region. We conducted our own study of 200 children with CHD; 5% of cases were syndromic forms of CHD. 48.5% of children were admitted to the cardiac surgery clinic in critical condition. A decrease in the TREC level was detected in 23.5% of cases, including all children with syndromic CHD. In the group of patients with immunological disorders, there were significantly more children with cyanotic CHD, children admitted in critical condition, and children with conotruncal defects. Infectious complications in the postoperative period (sepsis, pneumonia, tracheobronchitis, postoperative wound infection) were observed significantly more often in 47 children with reduced TREC levels compared to children with normal TREC levels ( = .00000, in 36% and 3.6%, respectively). The analysis of publications confirms the prognostic value of TREC and KREC screening for targeted preoperative preparation to reduce postoperative complications and decrease the risk of mortality in CHDs.

© 2025 The Author(s). Published by Bentham Science Publisher.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963325523250320065040
2025-03-26
2025-10-30

  • From This Site

    /content/journals/cpr/10.2174/0115733963325523250320065040
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cpr/10.2174/0115733963325523250320065040/BMS-CPR-2024-41.html?itemId=/content/journals/cpr/10.2174/0115733963325523250320065040&mimeType=html&fmt=ahah

References

  1. Praagh V.R. Diagnosis of complex congenital heart disease: Morphologic-anatomic method and terminology. Cardiovasc. Intervent. Radiol. 1984 7 3-4 115 120 10.1007/BF02552810 6467256
    [Google Scholar]
  2. Bockeria L. Shatalov K. Pediatric cardiac surgery: A guide for doctors Мoscow Research Center for Cardiovascular Surgery named after A.N. Bakulev. 2016 864 864
    [Google Scholar]
  3. Hoffman J.i.e. Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002 39 12 1890 1900 10.1016/S0735‑1097(02)01886‑7 12084585
    [Google Scholar]
  4. Kemper A.R. Mahle W.T. Martin G.R. Cooley W.C. Kumar P. Morrow W.R. Kelm K. Pearson G.D. Glidewell J. Grosse S.D. Howell R.R. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011 128 5 e1259 e1267 10.1542/peds.2011‑1317 21987707
    [Google Scholar]
  5. Hoffman J.i.e. The global burden of congenital heart disease : Review article. Cardiovasc. J. Afr. 2013 24 4 141 145 10.5830/CVJA‑2013‑028 24217047
    [Google Scholar]
  6. Bravo-valenzuela N.J. Peixoto A.B. Júnior A.E. Prenatal diagnosis of congenital heart disease: A review of current knowledge. Indian Heart J. 2018 70 1 150 164 10.1016/j.ihj.2017.12.005 29455772
    [Google Scholar]
  7. Helman S.M. Herrup E.A. Christopher A.B. Al-Zaiti S.S. The role of machine learning applications in diagnosing and assessing critical and non-critical CHD: A scoping review. Cardiol. Young 2021 31 11 1770 1780 10.1017/S1047951121004212 34725005
    [Google Scholar]
  8. Ferencz C. Neill C.A. Boughman J.A. Rubin J.D. Brenner J.I. Perry L.W. Congenital cardiovascular malformations associated with chromosome abnormalities: An epidemiologic study. J. Pediatr. 1989 114 1 79 86 10.1016/S0022‑3476(89)80605‑5 2521249
    [Google Scholar]
  9. Pober B.R. Overview of epidemiology, genetics, birth defects, and chromosome abnormalities associated with CDH. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. Hoboken, New Jersey Wiley Online Library 2007
    [Google Scholar]
  10. Nwafor I.A. Eze J.C. Status of congenital heart defects in Nigeria: The role of cardiac surgery. World J. Cardiovasc. Surg. 2019 9 7 63 72 10.4236/wjcs.2019.97008
    [Google Scholar]
  11. Arvind B. Saxena A. Timing of Interventions in infants and children with congenital heart defects. Indian J. Pediatr. 2020 87 4 289 294 10.1007/s12098‑019‑03133‑w 31970668
    [Google Scholar]
  12. Shmukler A. Haramati A. Haramati L.B. Overview of Common Surgical Procedures in CHD. Seminars in Roentgenology. Amsterdam, Netherlands Elsevier 2020
    [Google Scholar]
  13. Corno A.F. Koerner T.S. Salazar J.D. Innovative treatments for congenital heart defects. World J. Pediatr. 2023 19 1 1 6 10.1007/s12519‑022‑00654‑x 36481963
    [Google Scholar]
  14. Mavroudis C. Backer C. Anderson R. Spicer D. Jacobs J.P. Rigsby C. Pediatric cardiac surgery. Hoboken, New Jersey John Wiley & Sons 2023 10.1002/9781119282327
    [Google Scholar]
  15. Costello J.M. Pasquali S.K. Jacobs J.P. He X. Hill K.D. Cooper D.S. Backer C.L. Jacobs M.L. Gestational age at birth and outcomes after neonatal cardiac surgery: An analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Circulation 2014 129 24 2511 2517 10.1161/CIRCULATIONAHA.113.005864 24795388
    [Google Scholar]
  16. Zelenikin M. Degtyareva E. Lobacheva G. Khakhina L. The importance of preoperative prevention of specific pneumonia in infected cardiac surgical patients of early age. Rus. J. Thorac. Cardiov. Sur. 1997 5 27 30
    [Google Scholar]
  17. Healy F. Hanna B.D. Zinman R. Pulmonary complications of congenital heart disease. Paediatr. Respir. Rev. 2012 13 1 10 15 10.1016/j.prrv.2011.01.007 22208788
    [Google Scholar]
  18. Murni I.K. MacLaren G. Morrow D. Iyer P. Duke T. Perioperative infections in congenital heart disease. Cardiol. Young 2017 27 S6 S14 S21 10.1017/S1047951117002578 29198258
    [Google Scholar]
  19. Woodward C.S. Keeping children with congenital heart disease healthy. J. Pediatr. Health Care 2011 25 6 373 378 10.1016/j.pedhc.2011.03.007 22018428
    [Google Scholar]
  20. Navas L. Wang E. Carvalho D.V. Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J. Pediatr. 1992 121 3 348 354 10.1016/S0022‑3476(05)90000‑0 1517907
    [Google Scholar]
  21. Kristensen K. Stensballe L.G. Bjerre J. Roth D. Fisker N. Kongstad T. Svendsen A.L. Nielsen B.W. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch. Dis. Child. 2009 94 10 785 789 10.1136/adc.2008.143057 19541682
    [Google Scholar]
  22. Degtyareva E. Pavlova E. Ovsyannikov D. Features of the course of pneumonia in infants with congenital heart defects. Nat. Tech. Sci. 2011 5 194 195
    [Google Scholar]
  23. Degtyareva E. Pavlova E. Ovsyannikov D. Vavilova G. Pneumonia in infants with congenital heart defects. Journal “Pediatria” named after G.N. Speransky. 2011 90 6 164
    [Google Scholar]
  24. Habib G. Hoen B. Tornos P. Thuny F. Prendergast B. Vilacosta I. Moreillon P. Antunes J.D.M. Thilen U. Lekakis J. Lengyel M. Müller L. Naber C.K. Nihoyannopoulos P. Moritz A. Zamorano J.L. Vahanian A. Auricchio A. Bax J. Ceconi C. Dean V. Filippatos G. Funck-Brentano C. Hobbs R. Kearney P. McDonagh T. McGregor K. Popescu B.A. Reiner Z. Sechtem U. Sirnes P.A. Tendera M. Vardas P. Widimsky P. Vahanian A. Aguilar R. Bongiorni M.G. Borger M. Butchart E. Danchin N. Delahaye F. Erbel R. Franzen D. Gould K. Hall R. Hassager C. Kjeldsen K. McManus R. Miro J.M. Mokracek A. Rosenhek R. San Roman Calvar J.A. Seferovic P. Selton-Suty C. Uva M.S. Trinchero R. Camp V.G. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The task force on the prevention, diagnosis, and treatment of infective endocarditis of the european society of cardiology (ESC). Eur. Heart J. 2009 30 19 2369 2413 10.1093/eurheartj/ehp285 19713420
    [Google Scholar]
  25. Babu S. Sreedhar R. Munaf M. Gadhinglajkar S.V. Sepsis in the pediatric cardiac intensive care unit: An updated review. J. Cardiothorac. Vasc. Anesth. 2023 37 6 1000 1012 10.1053/j.jvca.2023.02.011 36922317
    [Google Scholar]
  26. Radford D.J. Thong Y.H. The association between immunodeficiency and congenital heart disease. Pediatr. Cardiol. 1988 9 2 103 108 10.1007/BF02083708 3041386
    [Google Scholar]
  27. Radford D.J. Thong Y.H. Beard L.J. Ferrante A. IgG subclass deficiency in children with congenital heart disease. Pediatr. Allergy Immunol. 1990 1 1 41 45 10.1111/j.1399‑3038.1990.tb00007.x
    [Google Scholar]
  28. Degtyareva E.A. Samuilova D.S. Razuvaev M.K. Khurges I.S. Immunological screening and immune correction in cardiosurgery of infants. Bull. Exp. Biol. Med. 1993 115 4 417 421 10.1007/BF00850920
    [Google Scholar]
  29. Delves P.J. Roitt I.M. The immune system. First of two parts. N. Engl. J. Med. 2000 343 1 37 49 10.1056/NEJM200007063430107 10882768
    [Google Scholar]
  30. Petrov R.V. Khaitov R.M. Chereshnev V.A. Physiology of the immune system: Cellular and molecular biological mechanisms. Bullet. Russ. Found. Basic Res. 2017 1 96 119 [In Russian].
    [Google Scholar]
  31. Farmer J.R. Mahajan V.S. Molecular diagnosis of inherited immune disorders. Clin. Lab. Med. 2019 39 4 685 697 10.1016/j.cll.2019.07.013 31668278
    [Google Scholar]
  32. Tangye S.G. Al-Herz W. Bousfiha A. Chatila T. Cunningham-Rundles C. Etzioni A. Franco J.L. Holland S.M. Klein C. Morio T. Ochs H.D. Oksenhendler E. Picard C. Puck J. Torgerson T.R. Casanova J.L. Sullivan K.E. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 2020 40 1 24 64 10.1007/s10875‑019‑00737‑x 31953710
    [Google Scholar]
  33. Vries D.E. Patient-centred screening for primary immunodeficiency: A multi-stage diagnostic protocol designed for non-immunologists. Clin. Exp. Immunol. 2006 145 2 204 214 10.1111/j.1365‑2249.2006.03138.x 16879238
    [Google Scholar]
  34. Korsunskiy I.A. Gordukova M.A. Munblit D.B. Kozlov I.G. Prodeus A.P. Korsunskiy A.A. Clinical and epidemiological aspects of primary immunodeficiency diseases (PID) and early diagnosis options. Medical Immunology 2017 19 5 505 512 10.15789/1563‑0625‑2017‑5‑505‑512
    [Google Scholar]
  35. Mukhina A.A. Kuzmenko N.B. Rodina Y.A. Kondratenko I.V. Bologov A.A. Latysheva T.V. Prodeus A.P. Pampura A.N. Balashov D.N. Ilyina N.I. Latysheva E.A. Deordieva E.A. Shvets O.A. Deripapa E.V. Abramova I.N. Pashenko O.E. Vahlyarskaya S.S. Zinovyeva N.V. Zimin S.B. Skorobogatova E.V. Machneva E.B. Fomina D.S. Ipatova M.G. Barycheva L.Y. Khachirova L.S. Tuzankina I.A. Bolkov M.A. Shakhova N.V. Kamaltynova E.M. Sibgatullina F.I. Guseva M.N. Kuznetsova R.N. Milichkina A.M. Totolian A.A. Kalinina N.M. Goltsman E.A. Sulima E.I. Kutlyanceva A.Y. Moiseeva A.A. Khoreva A.L. Nesterenko Z. Tymofeeva E.V. Ermakova A. Proligina D.D. Kalmetieva L.R. Davletbaieva G.A. Mirsayapova I.A. Richkova O.A. Kuzmicheva K.P. Grakhova M.A. Yudina N.B. Orlova E.A. Selezneva O.S. Piskunova S.G. Samofalova T.V. Bukina T.V. Pechkurova A.D. Migacheva N. Zhestkov A. Barmina E.V. Parfenova N.A. Isakova S.N. Averina E.V. Sazonova I.V. Starikova S.Y. Shilova T.V. Asekretova T.V. Suprun R.N. Kleshchenko E.I. Lebedev V.V. Demikhova E.V. Demikhov V.G. Kalinkina V.A. Gorenkova A.V. Duryagina S.N. Pavlova T.B. Shinkareva V.M. Smoleva I.V. Aleksandrova T.P. Bambaeva Z.V. Philippova M.A. Gracheva E.M. Tcyvkina G.I. Efremenkov A.V. Mashkovskaya D. Yarovaya I.V. Alekseenko V.A. Fisyun I.V. Molokova G.V. Troitskya E.V. Piatkina L.I. Vlasova E.V. Ukhanova O. Chernishova e.g. Vasilieva M. Laba O.M. Volodina E. Safonova E.V. Voronin K.A. Gurkina M.V. Rumyantsev A.G. Novichkova G.A. Shcherbina A.Y. Primary immunodeficiencies in russia: Data from the national registry. Front. Immunol. 2020 11 1491 10.3389/fimmu.2020.01491 32849507
    [Google Scholar]
  36. Cheremokhin D.A. Phenotypic and molecular genetic aspects of primary immunodeficiencies in children with congenital heart defects. PhD. Thes. Med. 2022 149 119 146
    [Google Scholar]
  37. Diller G.P. Lammers A.E. Fischer A. Orwat S. Nienhaus K. Schmidt R. Radke R.M. De-Torres-Alba F. Kaleschke G. Marschall U. Bauer U.M. Roth J. Gerß J. Bormann E. Baumgartner H. Immunodeficiency is prevalent in congenital heart disease and associated with increased risk of emergency admissions and death. Eur. Heart J. 2023 44 34 3250 3260 10.1093/eurheartj/ehad029 36747318
    [Google Scholar]
  38. Freedom R.M. Rosen F.S. Nadas A.S. Congenital cardiovascular disease and anomalies of the third and fourth pharyngeal pouch. Circulation 1972 46 1 165 172 10.1161/01.CIR.46.1.165 5039819
    [Google Scholar]
  39. Levin S. Schlesinger M. Handzel Z. Hahn T. Altman Y. Czernobilsky B. Boss J. Thymic deficiency in down’s syndrome. Pediatrics 1979 63 1 80 87 10.1542/peds.63.1.80 155804
    [Google Scholar]
  40. Moerman P. Goddeeris P. Lauwerijns J. Hauwaert D.V.L.G. Cardiovascular malformations in DiGeorge syndrome (congenital absence of hypoplasia of the thymus). Heart 1980 44 4 452 459 10.1136/hrt.44.4.452 7426208
    [Google Scholar]
  41. Digilio M.C. Marino B. Toscano A. Giannotti A. Dallapiccola B. Congenital heart defects in Kabuki syndrome. Am. J. Med. Genet. 2001 100 4 269 274 10.1002/ajmg.1265 11343317
    [Google Scholar]
  42. Wienecke L.M. Cohen S. Bauersachs J. Mebazaa A. Chousterman B.G. Immunity and inflammation: The neglected key players in congenital heart disease? Heart Fail. Rev. 2022 27 5 1957 1971 10.1007/s10741‑021‑10187‑6 34855062
    [Google Scholar]
  43. Ahmed A. Lippner E. Khanolkar A. Clinical aspects of B cell immunodeficiencies: The past, the present and the future. Cells 2022 11 21 3353 10.3390/cells11213353 36359748
    [Google Scholar]
  44. Kiani A.A. Elyasi H. Ghoreyshi S. Nouri N. Safarzadeh A. Nafari A. Study on hypoxia-inducible factor and its roles in immune system. Immunol. Med. 2021 44 4 223 236 10.1080/25785826.2021.1910187 33896415
    [Google Scholar]
  45. Chen Y. Gaber T. Hypoxia/HIF modulates immune responses. Biomedicines 2021 9 3 260 10.3390/biomedicines9030260 33808042
    [Google Scholar]
  46. Hammarström L Smith CE Genetic approach to common variable immunodeficiency and IgA deficiency. Primary Immunodeficiency Diseases. Hans D. Ochs C. Smith E. New York, NY A molecular and genetic approach 2007 250 262
    [Google Scholar]
  47. Bonilla F.A. Barlan I. Chapel H. Costa-Carvalho B.T. Cunningham-Rundles C. Morena L.D.M.T. Espinosa-Rosales F.J. Hammarström L. Nonoyama S. Quinti I. Routes J.M. Tang M.L.K. Warnatz K. International Consensus Document (ICON): Common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract. 2016 4 1 38 59 10.1016/j.jaip.2015.07.025 26563668
    [Google Scholar]
  48. Sun J. Yang L. Lu Y. Wang H. Peng X. Dong X. Cheng G. Cao Y. Wu B. Wang X. Zhou W. Screening for primary immunodeficiency diseases by next-generation sequencing in early life. Clin. Transl. Immunology 2020 9 5 e1138 10.1002/cti2.1138 32431812
    [Google Scholar]
  49. Jian M. Wang X. Sui Y. Fang M. Gao Y. Guo R. Newborn screening in unselected children using genomic sequencing. Res. Squ. 2021 1 9 10.21203/rs.3.rs‑143405/v1
    [Google Scholar]
  50. Rodriguez J.A. Bang T.J. Restrepo C.S. Green D.B. Browne L.P. Vargas D. Imaging features of primary immunodeficiency disorders. Radiol. Cardiothorac. Imaging 2021 3 2 e200418 10.1148/ryct.2021200418 33969305
    [Google Scholar]
  51. Degtyareva E.A. The importance of non-surgical factors in improving the results of surgical treatment of congenital heart defects. Abstract of the Ph.D. (Medicine) thesis. / Degtyareva, Elena Aleksandrovna. Moscow 1996
    [Google Scholar]
  52. Cocks B.G. Chang C.C.J. Carballido J.M. Yssel H. Vries D.J.E. Aversa G. A novel receptor involved in T-cell activation. Nature 1995 376 6537 260 263 10.1038/376260a0 7617038
    [Google Scholar]
  53. Spek D.V.J. Groenwold R.H.H. Burg D.V.M. Montfrans V.J.M. TREC based newborn screening for severe combined immunodeficiency disease: A systematic review. J. Clin. Immunol. 2015 35 4 416 430 10.1007/s10875‑015‑0152‑6 25893636
    [Google Scholar]
  54. Korsunskiy I. Blyuss O. Gordukova M. Davydova N. Gordleeva S. Molchanov R. Asmanov A. Peshko D. Zinovieva N. Zimin S. Lazarev V. Salpagarova A. Filipenko M. Kozlov I. Prodeus A. Korsunskiy A. Hsu P. Munblit D. TREC and KREC levels as a predictors of lymphocyte subpopulations measured by flow cytometry. Front. Physiol. 2019 9 1877 10.3389/fphys.2018.01877 30719006
    [Google Scholar]
  55. Shinwari K Bolkov M Tuzankina IA Chereshnev VA Newborn screening through TREC, TREC/KREC system for primary immunodeficiency with limitation of TREC/KREC. comprehensive review. Antiinflamm. Antiall. Agents Med. Chem. 20 2 132 149 10.2174/1871523019999200730171600 2021
    [Google Scholar]
  56. Kwok J.S.Y. Cheung S.K.F. Ho J.C.Y. Tang I.W.H. Chu P.W.K. Leung E.Y.S. Lee P.P.W. Cheuk D.K.L. Lee V. Ip P. Lau Y.L. Establishing simultaneous T cell receptor excision circles (TREC) and K-deleting recombination excision circles (KREC) quantification assays and laboratory reference intervals in healthy individuals of different age groups in Hong Kong. Front. Immunol. 2020 11 1411 10.3389/fimmu.2020.01411 32765500
    [Google Scholar]
  57. Medova V. Hulinkova I. Laiferova N. Urdova V. Ciznar P. Dolnikova D. Krasnanova V. Fabri O. Ficek A. Soltysova A. The importance of defining the age-specific TREC/KREC levels for detection of various inborn errors of immunity in pediatric and adult patients. Clin. Immunol. 2022 245 109155 10.1016/j.clim.2022.109155 36243346
    [Google Scholar]
  58. Marcovecchio G.E. Bortolomai I. Ferrua F. Fontana E. Imberti L. Conforti E. Amodio D. Bergante S. Macchiarulo G. D’Oria V. Conti F. Cesare D.S. Fousteri G. Carotti A. Giamberti A. Poliani P.L. Notarangelo L.D. Cancrini C. Villa A. Bosticardo M. Thymic epithelium abnormalities in DiGeorge and Down syndrome patients contribute to dysregulation in T cell development. Front. Immunol. 2019 10 447 10.3389/fimmu.2019.00447 30949166
    [Google Scholar]
  59. Chinen J. Shearer W.T. Secondary immunodeficiencies, including HIV infection. J. Allergy Clin. Immunol. 2010 125 2 Suppl. 2 S195 S203 10.1016/j.jaci.2009.08.040 20042227
    [Google Scholar]
  60. Zelm V.M.C. Burg D.V.M. Langerak A.W. Dongen V.J.J.M. PID comes full circle: Applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front. Immunol. 2011 2 12 10.3389/fimmu.2011.00012 22566803
    [Google Scholar]
  61. Marinova M. Georgyeva A. Yordanova V. Ivanov N. Atanasova V. Naumova E. Kandilarova S.M. Implementation of TREC/KREC detection protocol for newborn SCID screening in Bulgaria: A pilot study. Cent. Eur. J. Immunol. 2022 47 4 339 349 10.5114/ceji.2022.124396 36817401
    [Google Scholar]
  62. Martínez-Morillo E. García P.B. Menéndez A.F.V. Challenges for worldwide harmonization of newborn screening programs. Clin. Chem. 2016 62 5 689 698 10.1373/clinchem.2015.240903 27001491
    [Google Scholar]
  63. King J. Ludvigsson J. Hammarström L. Newborn screening for primary immunodeficiency diseases: The past, the present and the future. Int. J. Neonatal Screen. 2017 3 3 19 10.3390/ijns3030019
    [Google Scholar]
  64. Korsunsky D.A. Kudlay A.P. Prodeus A.Yu. Shcherbina A.G. Neonatal screening for primary immunodeficiency and T-/B-cell lymphopenia as the basis for the formation of risk groups for children with congenital pathologies. Pediatria n.a. G.N. Speransky. 2020 99 2 8 15 10.24110/0031‑403X‑2020‑99‑2‑8‑15
    [Google Scholar]
  65. Loeber J.G. Platis D. Zetterström R.H. Almashanu S. Boemer F. Bonham J.R. Borde P. Brincat I. Cheillan D. Dekkers E. Dimitrov D. Fingerhut R. Franzson L. Groselj U. Hougaard D. Knapkova M. Kocova M. Kotori V. Kozich V. Kremezna A. Kurkijärvi R. Marca L.G. Mikelsaar R. Milenkovic T. Mitkin V. Moldovanu F. Ceglarek U. O’Grady L. Oltarzewski M. Pettersen R.D. Ramadza D. Salimbayeva D. Samardzic M. Shamsiddinova M. Songailiené J. Szatmari I. Tabatadze N. Tezel B. Toromanovic A. Tovmasyan I. Usurelu N. Vevere P. Vilarinho L. Vogazianos M. Yahyaoui R. Zeyda M. Schielen P.C.J.I. Neonatal screening in Europe revisited: An ISNS perspective on the current state and developments since 2010. Int. J. Neonatal Screen. 2021 7 1 15 10.3390/ijns7010015 33808002
    [Google Scholar]
  66. Blom M. Bredius R.G.M. Jansen M.E. Weijman G. Kemper E.A. Vermont C.L. Hollink I.H.I.M. Dik W.A. Montfrans V.J.M. Gijn V.M.E. Henriet S.S. Aerde V.K.J. Koole W. Lankester A.C. Dekkers E.H.B.M. Schielen P.C.J.I. Vries D.M.C. Henneman L. Burg D.V.M. Parents’ perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands. J. Clin. Immunol. 2021 41 1 99 108 10.1007/s10875‑020‑00886‑4 33070266
    [Google Scholar]
  67. Kozlov V.A. Tikhonova E.P. Savchenko A.A. Kudryavtsev I.V. Andronova N.V. Anisimova E.N. Clinical immunology: A practical manual for infectious diseases specialists. Krasn. Polikor. 2021 563 1 6 10.17513/np.518
    [Google Scholar]
  68. Jiang T. Li Z. Zhang Q. Advances in neonatal screening for primary immune deficiencies. Exp. Ther. Med. 2016 11 5 1542 1544 10.3892/etm.2016.3119 27168770
    [Google Scholar]
  69. Barbaro M. Ohlsson A. Borte S. Jonsson S. Zetterström R.H. King J. Winiarski J. Döbeln V.U. Hammarström L. Newborn screening for severe primary immunodeficiency diseases in Sweden—a 2-year pilot TREC and KREC screening study. J. Clin. Immunol. 2017 37 1 51 60 10.1007/s10875‑016‑0347‑5 27873105
    [Google Scholar]
  70. Kennedy K. Rychik J. Heimall J. Dodds K. TREC screening in pediatric patients with congenital heart disease. J. Allergy Clin. Immunol. 2020 145 2 AB213 10.1016/j.jaci.2019.12.243
    [Google Scholar]
  71. Degtyareva E.A. Prodeus A.P. Mvela B.M. Kim A.I. Nefedova i.e. Rogova T.V. New methods for preoperative diagnosis of immunodeficiency in children with congenital heart defects for predicting and preventing infectious complications of cardiac surgery. Second All-Russian Congress of Pediatric Cardiac Surgeons and Specialists on Congenital Heart Defects (with international participation) 2023. pp. 842023.
    [Google Scholar]
  72. Gul K.A. Øverland T. Osnes L. Baumbusch L.O. Pettersen R.D. Lima K. Abrahamsen T.G. Neonatal levels of T-cell receptor excision circles (TREC) in patients with 22q11. 2 deletion syndrome and later disease features. J. Clin. Immunol. 2015 35 4 408 415 10.1007/s10875‑015‑0153‑5 25814142
    [Google Scholar]
  73. Singampalli K.L. Jui E. Shani K. Ning Y. Connell J.P. Birla R.K. Bollyky P.L. Caldarone C.A. Keswani S.G. Grande-Allen K.J. Congenital heart disease: An immunological perspective. Front. Cardiovasc. Med. 2021 8 701375 10.3389/fcvm.2021.701375 34434978
    [Google Scholar]
  74. Dar N. Gothelf D. Korn D. Frisch A. Weizman A. Michaelovsky E. Carmel M. Yeshayahu Y. Dubnov-Raz G. Pessach I.M. Simon A.J. Lev A. Somech R. Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome. Pediatr. Res. 2015 77 4 579 585 10.1038/pr.2015.14 25580739
    [Google Scholar]
/content/journals/cpr/10.2174/0115733963325523250320065040
Loading

  • Article Type:     Review Article
Keywords: immunodeficiency disorder (IDD) ; secondary immunodeficiency ; Congenital heart defect (CHD) ; primary immunodeficiency (PID) ; KREC ; TREC ; immunity studies

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test